Categories
Blog Education Featured

Cannabis legislation a priority to U.S. House and Senate members in 2021

With the start of the new year, several bills are expected to be introduced by Congress in the name of cannabis legislation and reform. Two congressional bills have, in fact, already been filed but Rep. Greg Steube (R-FL). The first introduced bill is identical to the previously proposed, The Marijuana 1-to-3 Act of 2019. This measure would reschedule Marijuana to a Schedule III with the goal to increase research on the therapeutic effects. The second filed legislation is The Veterans Cannabis Use for Safe Healing Act, to “prohibit the Secretary of Veterans Affairs from denying a veteran benefits due to the use of medical marijuana in states where the substance is legal.” 

 

These introduced bills show promise, but advocates are looking for more change in terms of cannabis reform, especially considering that the Democrats now have control of both the House and the Senate. Last year the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act was introduced to federally legalize marijuana. While this passed through the House it did not pass the Senate. To speak to the re-approach of the bill, Rep. Earl Blumenauer (D-OR) stated on his Twitter on February 1st, “We look forward to working with the Senate to refine the bill, advance its core criminal justice and restorative justice provisions, and end the failed federal prohibition of cannabis once and for all.” 

 

Senate Majority Leader Chuck Schumer (D-NY) has stated that cannabis reform is a priority for 2021. On February 1st he announced on Twitter that “The War on Drugs has been a war on people, and particularly people of color. Ending the federal marijuana prohibition is necessary to right the wrongs of this failed war.” Schumer is working alongside Sen. Cory Booker (D-NJ) and Senate Finance Committee Chairman Ron Wyden (D-OR) to release draft legislation in the coming weeks, detailing the proposed policy change at a federal level. Their released, joint statement shows promise for “comprehensive reform to ensure restorative justice, protect public health and implement responsible taxes and regulations.”

 

 

 

Realm of Caring Foundation (RoC), is a 501(c)3 nonprofit organization that was established by parents in 2013 to support families who were out of medical options. By creating educational resources, conducting research, and assisting families with data-rich answers to their questions, RoC continues to be a leader in the cannabinoid (cannabis/hemp) field. RoC’s no-cost Care Team has served more than 65,000 clients worldwide and supports a network of over 2,000 medical professionals. To learn more about participating or to donate to this cause, visit www.realmofcaring.org or call 1-888-210-3772.    

Categories
Blog Education

Cannabinoid therapy for Autism Spectrum Disorders (ASD)

Observational studies and trials in both humans and rodents in recent years have reported the beneficial use of cannabinoids in the form of cannabidiol (CBD) cannabis and hemp extracts as a therapeutic potential for ASD. In addition to being beneficial, these studies have also reported that, even in adolescents, the side effects of the cannabis extracts were either nonexistent or less frequent than those who reported drugs that are traditionally used for ASD, ADHD, sleep disorders, or epilepsy. 

 

When considering ASD, there are currently no defined drugs or psychotherapeutic approaches capable of extensively improving the quality of life, social skills, and cognitive functioning of the most severe cases. While the currently available drugs may mitigate certain symptoms, the effectiveness is, reportedly, limited and may have undesirable side effects. So, how is it then, that cannabinoid therapy may work differently with the body to possibly provide therapeutic benefit? To understand the difference of cannabinoid therapy in comparison to the available, conventional treatments it is helpful to first gain an understanding of the Endocannabinoid System (ECS) these plant cannabinoids are interacting with.

 

The ECS is the largest neurotransmitter system in the body, involved in regulating nearly every physiological process. It is composed of two receptors called CB1 and CB2 receptors, endocannabinoids, and metabolizing enzymes. Two key endocannabinoids have been identified as Anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These endocannabinoids are responsible for activating the CB1 and CB2 receptors that are found throughout our bodies and brains. Once endocannabinoids activate these receptors, physiological actions take place. 

 

Research has shown that one thing individuals with ASD have in common, is that AEA levels are more reduced than in non-ASD individuals. This is a concept known as clinical endocannabinoid deficiency (CED), a theory presented in 2001 and more thoroughly explored in 2004, where decreased AEA levels were found to be associated with a lower pain threshold, post traumatic stress disorder (PTSD), gastrointestinal disorders, and inflammation. 

 

When experiencing a deficiency of endocannabinoids, such as decreased AEA levels, research suggests the benefit of naturally increasing levels with the modulating cannabis compound, CBD. By supplementing with phytocannabinoids, like CBD, we may be able to mimic the action of those endocannabinoids to fill in gaps of deficiency, which means those decreased levels may become normalized. 

 

Since discovering this connection between decreased AEA levels and ASD, it has been shown that AEA modulation may potentially improve some aspects of behaviors, such as anxiety, without affecting social behaviors. There have even been suggestions that increasing AEA activity at CB1 receptor sites may actually lead to prosocial behavior. AEA modulation has also been linked as an important role in those with epileptic conditions. 

 

In addition to modulating AEA levels, CBD has been researched for its modulating benefits in other physiological processes. This includes how effectively our body may facilitate the serotonin it creates, allowing for more regulation of our moods. It also includes the shifting of glutamate and inhibitory y-aminobutyric acid (GABA), which may regulate excitatory and inhibitory neurotransmission in the brain. Due to the many processes CBD may modulate, participants in studies have seen a reduction in anxiety, cognitive impairment, and discomfort factors as well as an increase in the processing of emotional information.

 

Getting started with cannabinoid therapy can be overwhelming, especially when considering a neurodevelopmental disorder as complex as ASD. Most of the evidence of the efficacy of CBD with ASD comes from anecdotal and observational data; so although findings conclude that the cannabinoid is safe and may provide relief for associated symptoms, there is plenty of room for further clinical research to explore the full therapeutic potential of CBD, as well as the ability of other cannabinoids to potentiate its ability. 

 

If you are seeking data-driven answers to your questions about this cannabinoid therapy and ASD, Realm of Caring (RoC) can help. RoC has 8 years of collected data and research based on individuals utilizing plant-based therapies. They can guide you through product selection, dosing and administration, how to talk with your doctor, and the results individuals are realizing.

 

The RoC Care Team is here to assist. They care a lot about helping you to find success. Reach them by calling (719) 347-5400, emailing info@realmofcaring.org, or by scheduling appointment.

 

 

Disclaimer
The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

Categories
Blog Education

Three Things to Know About Terpenes

Here at Realm of Caring, we strive to educate our clients on the science behind cannabis. One of the most popular questions we get is, “What is a terpene?”. Terpenes play an important part in cannabinoid therapy as they may enhance therapeutic effects. In an effort to get you to know more about them, we have here the three things to know about terpenes. 

 

#1. What is a Terpene?

 

To put it in simple terms, terpenes are compounds produced by plants such as fruits, trees, herbs, and a variety of other plant species that are responsible for determining their distinct scents. Terpenes are so abundant in nature that they form the largest group of plant chemicals. They are commonly used for food flavoring, cosmetic products, and as a natural folk medicine. Of all of the plants known to man, cannabis has more terpenes than any other, having over 100 identified

 

#2. What do Terpenes do?

 

Found in the flowers, roots, and leaves, plants use terpenes as a defense mechanism to protect themselves from the environment and predators. They release a strong odor and flavor that is intended to ward off certain insects or herbivores. Not only do they play a role in protecting plants, but research shows terpenes to have multiple health-promoting properties in humans. Many individuals will look for cannabis strains with specific terpenes for specific conditions. The therapeutic properties of terpenes combined with the therapeutic properties of cannabinoids may enhance the overall therapeutic effect that the cannabis plant can offer. This combination, known as the entourage effect, can improve effectiveness due to increased bioavailability and affinity to certain receptors. The cannabinoids and terpenes are essentially working as a team to provide optimal relief. 

 

#3. What are the most popular terpenes?

 

Of the more than 100 terpenes found in the cannabis plant, there are specific ones found in higher concentrations in certain cannabis and/or hemp strains. Below are six of the most popular terpenes found in cannabis and cannabis products, as well as some of their reported benefits.

 

Myrcene

Reported to have active sedating, potent anti-inflammatory, and analgesic and anxiolytic properties. 

Also found in lemongrass, basil, mangos, and thyme.

 

β-caryophyllene 

Reported to have anti-inflammatory, anti-bacterial, and antioxidant properties.

Also Found in black pepper, cloves, hops, rosemary, and copaiba.

 

α-humulene 

Reported to have anti-inflammatory and analgesic properties. 

Also Found in hops, sage, and ginseng.

 

Α-pinene

Reported to have anti-inflammatory and anxiolytic properties as well as aid in cognitive function and as a bronchodilator. 

Also Found in pine needles, hops, mint, holy basil, and camphor.

 

Limonene 

Reported to have anxiolytic, antioxidant, anti-inflammatory, and anticancer properties. 

Also found in most citrus fruit peels such as oranges, lemon, and lime. 

 

Linalool 

Reported to have sedative, analgesic, anxiolytic, anti-microbial, anti-inflammatory, and anticonvulsant properties. 

Also Found in lavender, birch trees, sweet basil, and cinnamon. 

 

There is much research to be done on the many terpenes found in nature and how they react with other compounds and the human body to promote internal balance. Once you know what a terpene is and what it does, you will have a better understanding of how it can enhance your cannabinoid therapy. Give us your thoughts below or direct your questions to a care specialist at info@realmofcaring.org.

 

Disclaimer

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

 

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.